Preliminary study on chronic granulomatous disease in Sri Lanka.

Show simple item record

dc.contributor.author Fernando, Shalinda Jude Arjuna
dc.contributor.author Faiz, Noorul Mifra
dc.contributor.author Handunnetti, Shiroma Mangaika
dc.contributor.author De Silva, Aruna Dharshan
dc.contributor.author Dasanayake, Wasala Mudiyanselage Dhanushka Kumari
dc.contributor.author Wickramasinghe, Geethani Devika
dc.contributor.author Karunatilake, Rathnayake Mudiyanselage Chandima Hasanthi
dc.contributor.author de Silva, Nilhan Rajiva
dc.coverage.spatial England
dc.date.accessioned 2023-06-21T04:34:56Z
dc.date.available 2023-06-21T04:34:56Z
dc.date.issued 2018
dc.identifier.citation (2018). Allergy Asthma and Clinical Immunology, 14(1), 37-.
dc.identifier.issn 1710-1484
dc.identifier.uri https://hdl.handle.net/2292/64353
dc.description.abstract BACKGROUND: Chronic granulomatous disease (CGD) is a rare primary immunodeficiency of the phagocytic cells, which results in absent or diminished levels of microbicidal reactive oxygen species. The disease occurs due to germline mutations in the genes encoding the five subunits of NADPH oxidase complex. The present study is a pilot study to understand the clinical and genetic aspects of CGD in Sri Lanka. METHODS: Clinical records of thirteen CGD patients were analysed and compared with similar studies performed in different countries and regions to identify patterns in demographics, clinical manifestations and infectious agents. Genomic DNA and cDNA were analysed in eight patients to identify mutations in CYBB and NCF1 genes, thereby to ascertain the potential X-linked and autosomal recessive (AR) CGD patients. RESULTS: The onset of symptoms in the patient cohort was very early (mean 4.6 months) compared to 20 months in India and 23.9 months in Latin America. Similarly, the age at diagnosis was lower (mean 1.6 years after birth) compared to other studies; 4.5 years in India and 6.1 years in Europe. Pulmonary manifestations were the most common (85%), followed by skin/subcutaneous infections (77%) and lymphadenopathy (62%). The death rate of local patients (38%) was higher than other countries (India 35%, Europe 20%). Majority (77%) were treated for tuberculosis at some point in life. Genetic analysis confirmed six out of eight patients as X-linked CGD cases with mutations in CYBB gene. A novel splice site mutation was identified in P-07 at position c.141+6 which resulted in the deletion of entire exon 2. Two siblings (P-05 and P-06) from consanguineous parents, were identified with AR-CGD based on the homozygous GT deletion mutation in NCF1 gene. CONCLUSIONS: The clinical presentation, manifestations and genetic subtypes in the local cohort, appear to be comparable with global trends. Mycobacterial infections should be investigated and treated with more prominence. Effective treatment options are required to control the high mortality rate.
dc.language eng
dc.publisher Springer Nature
dc.relation.ispartofseries Allergy Asthma Clin Immunol
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm
dc.rights.uri https://creativecommons.org/licenses/by/4.0/
dc.subject Autosomal recessive
dc.subject CYBB
dc.subject Chronic granulomatous disease
dc.subject Mycobacterial infections
dc.subject NADPH oxidase
dc.subject NCF1
dc.subject Sri Lanka
dc.subject X-linked
dc.subject Genetics
dc.subject Clinical Research
dc.subject 2.1 Biological and endogenous factors
dc.subject 2 Aetiology
dc.subject 3 Good Health and Well Being
dc.subject 1107 Immunology
dc.title Preliminary study on chronic granulomatous disease in Sri Lanka.
dc.type Journal Article
dc.identifier.doi 10.1186/s13223-018-0264-7
pubs.issue 1
pubs.begin-page 37
pubs.volume 14
dc.date.updated 2023-05-31T01:25:26Z
dc.rights.holder Copyright: The authors en
pubs.author-url https://www.ncbi.nlm.nih.gov/pubmed/30237823
pubs.publication-status Published online
dc.rights.accessrights http://purl.org/eprint/accessRights/OpenAccess en
pubs.subtype Journal Article
pubs.elements-id 963056
pubs.org-id Medical and Health Sciences
pubs.org-id Medical Sciences
dc.identifier.eissn 1710-1492
dc.identifier.pii 264
pubs.number 37
pubs.record-created-at-source-date 2023-05-31
pubs.online-publication-date 2018-09-17


Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics